NDUFB5 Activators represent a specialized category of chemical compounds designed to selectively enhance the activity of NDUFB5, a protein intricately involved in the functioning of mitochondrial complex I, a crucial component of the electron transport chain in mitochondria. Complex I, also known as NADH:ubiquinone oxidoreductase, plays a pivotal role in cellular respiration by facilitating the transfer of electrons from NADH to ubiquinone, a key step in the generation of cellular energy in the form of ATP. NDUFB5 is a subunit of complex I and is essential for its proper assembly and function. The development of NDUFB5 Activators represents a significant scientific effort to understand and modulate the activity of this protein, shedding light on its roles in mitochondrial biology. These activators are synthesized through sophisticated chemical engineering processes, with the aim of producing molecules that can specifically interact with NDUFB5, potentially enhancing its function or revealing its endogenous regulators. Designing effective NDUFB5 Activators necessitates a profound understanding of the protein's structure, including its subunit interactions and potential binding sites.
The exploration of NDUFB5 Activators involves a multidisciplinary research approach, integrating techniques from molecular biology, biochemistry, and structural biology to elucidate how these compounds interact with NDUFB5. Scientists employ protein expression and purification methods to obtain NDUFB5 for further analysis. Functional assays, including enzymatic assays and cellular experiments, are used to assess the impact of activators on NDUFB5-mediated electron transfer and complex I activity. Structural studies, such as X-ray crystallography or cryo-electron microscopy, are instrumental in determining the three-dimensional structure of NDUFB5 within complex I, identifying potential activator binding sites, and elucidating the conformational changes associated with activation. Computational modeling and molecular docking further aid in predicting the interactions between NDUFB5 and potential activators, guiding the rational design and optimization of these molecules for increased specificity and efficacy. Through this comprehensive research endeavor, the study of NDUFB5 Activators aims to advance our understanding of mitochondrial complex I, electron transport chain function, and the regulation of mitochondrial energy production, contributing to the broader field of mitochondrial biology and cellular energetics.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
β-Nicotinamide mononucleotide | 1094-61-7 | sc-212376 sc-212376A sc-212376B sc-212376C sc-212376D | 25 mg 100 mg 1 g 2 g 5 g | $110.00 $150.00 $220.00 $300.00 $600.00 | 4 | |
NMN is a precursor of NAD+, and increased NAD+ levels can enhance mitochondrial function, which may upregulate NDUFB5 expression as part of the complex I assembly. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, a sirtuin that can promote mitochondrial biogenesis, possibly influencing the expression of components of the respiratory chain, including NDUFB5. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone activates PPARγ, which can influence mitochondrial biogenesis and may indirectly upregulate NDUFB5 expression. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin is known to activate AMP-activated protein kinase (AMPK), leading to enhanced mitochondrial biogenesis, which could increase NDUFB5 expression. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
As a PPAR agonist, bezafibrate can stimulate mitochondrial biogenesis and potentially upregulate NDUFB5 as part of the increased demand for respiratory chain proteins. | ||||||
Coenzyme Q10 | 303-98-0 | sc-205262 sc-205262A | 1 g 5 g | $71.00 $184.00 | 1 | |
CoQ10 is a component of the electron transport chain, and supplementing it may indirectly increase the expression of other respiratory chain components, including NDUFB5. | ||||||
SRT1720 | 1001645-58-4 | sc-364624 sc-364624A | 5 mg 10 mg | $197.00 $364.00 | 13 | |
SRT1720 is a SIRT1 activator, and by promoting mitochondrial biogenesis, it might upregulate mitochondrial proteins such as NDUFB5. | ||||||
α-Lipoic Acid | 1077-28-7 | sc-202032 sc-202032A sc-202032B sc-202032C sc-202032D | 5 g 10 g 250 g 500 g 1 kg | $69.00 $122.00 $212.00 $380.00 $716.00 | 3 | |
Alpha-lipoic acid is involved in mitochondrial bioenergetics and might enhance the expression of NDUFB5 through its effects on mitochondrial function. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Another PPARγ agonist, Pioglitazone, may promote mitochondrial biogenesis, contributing to the potential upregulation of NDUFB5 expression. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $62.00 | ||
Leucine can stimulate mTOR signaling, which is implicated in protein synthesis and might indirectly impact NDUFB5 expression. | ||||||